LEADER 03385oam  2200721I  450 
001 9910799981703321
005 20230422044310.0
010   $a0-429-16231-6
010   $a1-4822-2103-9
010   $a1-280-05226-0
010   $a0-585-46503-7
010   $a9786610052264
010   $a0-203-48444-4
024 7 $a10.1201/b15045 
035   $a(CKB)1000000000255390
035   $a(EBL)181231
035   $a(OCoLC)133159570
035   $a(SSID)ssj0000108307
035   $a(PQKBManifestationID)11127637
035   $a(PQKBTitleCode)TC0000108307
035   $a(PQKBWorkID)10044699
035   $a(PQKB)10350235
035   $a(SSID)ssj0000277130
035   $a(PQKBManifestationID)11195727
035   $a(PQKBTitleCode)TC0000277130
035   $a(PQKBWorkID)10233696
035   $a(PQKB)11529950
035   $a(MiAaPQ)EBC181231
035   $a(Au-PeEL)EBL181231
035   $a(CaPaEBR)ebr10054229
035   $a(CaONFJC)MIL5226
035   $a(OCoLC)1000429995
035   $a(EXLCZ)991000000000255390
100   $a20180706d2000      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 04$aThe [Beta][subscript]3-adrenoreceptor /$fedited by A. Donny Strosberg
210  1$aLondon ;$aNew York :$cTaylor & Francis,$d2000.
215   $a1 online resource (189 p.)
225 1 $aTaylor & Francis series in pharmaceutical sciences
300   $aDescription based upon print version of record.
311   $a0-7484-0804-5 
320   $aIncludes bibliographical references (p. 125-166) and index.
327   $aBook Cover; Title; Contents; List of figures; List of tables; Contributors; Preface; Abbreviations used in this book; Structure and Function of the 3-Adrenoreceptor; Regulation of the 3-Adrenoreceptor Signalling Efficacy; Using Transgenic and Gene Knockout Techniques to Assess 3-Adrenoreceptor Function; 3-Adrenoreceptor Ligands and the Pharmacology of the 3-Adrenoreceptor; The Native Human 3-Adrenoreceptor; 3-Adrenoreceptor-Mediated Responses in Heart and Vessels; 3-Adrenoreceptors in Brown and White Adipocytes: Roles in Thermogenesis and Energy Balance
327   $aThe Putative '4'-Adrenoreceptor and Other Atypical -AdrenoreceptorsReferences; Index
330   $aThe Beta-3 Adrenoreceptor plays an important role in regulating human fat storage and variants of this receptor are thought to be relevant to diabetes.In addition to the major interest in obesity and diabetes expressed by the pharmaceutical industry, increasing numbers of academic groups are attracted by this general research area. This renewed interest is of course in part stimulated by available financing from industry. It also reflects the growing realisation that metabolism remains an open frontier: little is known about adipocyte sub-populations, specific markers, or endocrine functio
410  0$aTaylor & Francis series in pharmaceutical sciences.
517 3 $aBeta 3 adrenoreceptor
606   $aBeta adrenoceptors
606   $aAdrenergic beta agonists
615  0$aBeta adrenoceptors.
615  0$aAdrenergic beta agonists.
676   $a612/.01575
701   $aStrosberg$b A. D$01586677
801  0$bFlBoTFG
801  1$bFlBoTFG
906   $aBOOK
912   $a9910799981703321
996   $aThe subscript3-adrenoreceptor$93873408
997   $aUNINA